BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32090263)

  • 1. The Interplay Between Genetic Risk Factors and Proteolytic Dysregulation in the Pathophysiology of Inflammatory Bowel Disease.
    Solà-Tapias N; Vergnolle N; Denadai-Souza A; Barreau F
    J Crohns Colitis; 2020 Sep; 14(8):1149-1161. PubMed ID: 32090263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
    Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
    Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases.
    Dudarewicz M; Rychlik-Sych M; Barańska M; Wojtczak A; Trzciński R; Dziki A; Skrętkowicz J
    Pharmacol Rep; 2014 Aug; 66(4):686-90. PubMed ID: 24948072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
    Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
    Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.
    Cleynen I; Vazeille E; Artieda M; Verspaget HW; Szczypiorska M; Bringer MA; Lakatos PL; Seibold F; Parnell K; Weersma RK; Mahachie John JM; Morgan-Walsh R; Staelens D; Arijs I; De Hertogh G; Müller S; Tordai A; Hommes DW; Ahmad T; Wijmenga C; Pender S; Rutgeerts P; Van Steen K; Lottaz D; Vermeire S; Darfeuille-Michaud A
    Gut; 2014 Aug; 63(8):1265-74. PubMed ID: 24092863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics universe of Crohn's disease and ulcerative colitis.
    Parkes M
    Dig Dis; 2012; 30 Suppl 1():78-81. PubMed ID: 23075873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
    Yadav P; Ellinghaus D; Rémy G; Freitag-Wolf S; Cesaro A; Degenhardt F; Boucher G; Delacre M; ; Peyrin-Biroulet L; Pichavant M; Rioux JD; Gosset P; Franke A; Schumm LP; Krawczak M; Chamaillard M; Dempfle A; Andersen V
    Gastroenterology; 2017 Aug; 153(2):550-565. PubMed ID: 28506689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
    Scaldaferri F; Fiocchi C
    J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology and the pathogenesis of inflammatory bowel disease.
    Karlinger K; Györke T; Makö E; Mester A; Tarján Z
    Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease.
    Zhao M; Burisch J
    Dig Dis Sci; 2019 Jul; 64(7):1759-1769. PubMed ID: 31073736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.
    Ahluwalia B; Moraes L; Magnusson MK; Öhman L
    Scand J Gastroenterol; 2018 Apr; 53(4):379-389. PubMed ID: 29523023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
    Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.
    Ellinghaus D; Bethune J; Petersen BS; Franke A
    Scand J Gastroenterol; 2015 Jan; 50(1):13-23. PubMed ID: 25523552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis.
    Bridger S; Lee JC; Bjarnason I; Jones JE; Macpherson AJ
    Gut; 2002 Jul; 51(1):21-5. PubMed ID: 12077086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases].
    Zatorski H; Sałaga M; Zielińska M; Fichna J
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():335-44. PubMed ID: 25811470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.